Send us a textCloud computing is transforming biotech by offering purpose-built infrastructure that supports AI-driven drug discovery and development while meeting strict regulatory requirements. Dr. Ilya Burkov explains how Nebius provides full-stack solutions that democratize access to powerful technology, enabling researchers to achieve breakthroughs that previously required generations.• Cloud computing market was built for general purpose workloads but biotech needs specialized infrastructure for sensitive data and AI models• GPUs enable parallel processing that accelerates AI applications—like "a whole classroom solving math problems at once" versus CPUs solving one at a time• Applications include drug discovery, genomics, protein structure modeling, quantum chemistry, and single-cell modeling for cancer treatment• Nebius provides full-stack solutions with hardware and software layers, working with NVIDIA to offer specialized packages• Democratizing access to AI infrastructure is leveling the playing field between small biotechs and large pharmaceutical companies• Scientists can now accomplish in their lifetime what previously would have taken multiple generations of researchers• Breaking down silos between data teams and institutions is crucial for accelerating healthcare innovationSupport the show________Reach out to Ivanna RosendalJoin the conversation on our LinkedIn page

Ver todos los episodios